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1. Introduction 
Suppurative streptococcal infections of the throat and the skin generate stimuli that lead 
Rheumatic fever (RF) in 1 to 5% of susceptible children. The disease manifests initially as 
polyarthritis, carditis/valvulitis, Sydenham`s chorea, erythema marginatum and/or 
subcutaneous nodules. Chronic renal disease can also occur.  
RF occurs at an early phase of life (3 to 19 years of age); thus, heart damage (carditis) can 
appear in very young children. Rheumatic carditis usually presents as pancarditis, affecting 
the endocardium, myocardium and pericardium. Recurrent acute cardiac lesions frequently 
evolve into chronic rheumatic heart disease (RHD), of which valvular deformities are the 
most important sequelae; these deformities lead to mitral and aortic regurgitation and/or 
stenosis. Valve replacement surgery is usually the only treatment for chronic RHD patients 
and incurs high costs for both public and private health systems.  
Here, we will present three cases of young RHD patients who underwent valve replacement 
and the autoimmune reactivity that triggered the heart-tissue rheumatic lesions. 
Post-streptococcal glomerulonephritis (PSGN) is another immune sequelae that presents a 
latency period of one to three weeks after scarlet fever, streptococcal pharyngitis and 
purulent skin infections. 
PSGN has become a rare disease, especially in adults in developed countries, due to an 
improved standard of living, earlier treatment of pharyngeal infections and widespread use 
of antibiotics (Rodriguez-Iturbe & Musser, 2008). Despite decades of research, the 
pathogenesis of PSGN remains obscure. It is still unclear whether or to what extent 
autoimmune reactions are involved, but several studies have shown that different 
streptococcal antigens are detectable by immunohistology in the diseased kidneys 
(Rodriguez-Iturbe & Batsford, 2007). These data are in favor of direct contributions of 
streptococcal nephritogenic factors to PSGN pathogenesis, although intact bacteria have 
never been found in affected kidneys. Two PSGN cases will also be presented. 
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2. Epidemiology 
2.1 Acute rheumatic fever 
The incidence of ARF in some developing countries exceeds 50 cases per 100,000 children 
(Carapetis et al., 2005). The worldwide incidence of RHD is at least 15.6 million cases and is 
responsible for around 233,000 deaths / year. However, these estimates are based on 
conservative assumptions, so the true disease burden is probably substantially higher 
(Carapetis et al., 2005). The incidence of ARF can vary from 0.7 to 508 per 100,000 children 
per year in different populations from several countries (Carapetis et al., 2005). In Brazil, 
according to the WHO epidemiological model and data from IBGE (Brazilian Institute of 
Geography and Statistics), the number of Streptococcal pharyngitis infections is around 10 
million cases, which could lead to 30,000 new cases of RF, of which around 15,000 could 
develop cardiac lesions (Barbosa et al.,2009). 
2.2 Post-streptococcal glomerulonephritis (PSGN) 
PSGN has become a rare disease, especially in adults in developed countries, due to an 
improved standard of living, earlier treatment of pharyngeal infections and widespread use 
of antibiotics (Rodriguez-Iturbe & Musser, 2008). However, the occurrence of acute post-
infection glomerulonephritis (APIGN) has emerged as a major risk in diabetic patients all 
over the world (Nars et al., 2008). 
The global incidence of acute PSGN was estimated at 472,000 cases per year, of which 
456,000 occurred in less-developed countries (Carapetis, 2005). In agreement with these 
data, the incidence of PSGN ranges from 9.5 to 28.5 new cases per 100,000 individuals per 
year in developing countries (Rodríguez-Iturbe, 2008).  
3. Autoimmunity is the major mechanism leading to both diseases 
3.1 Rheumatic fever and rheumatic heart disease  
The autoimmune reactions in RF and RHD are controlled by several genes related to both the 
innate and adaptive immune responses (Guilherme et al., 2011). Briefly, in the last 50 years, 
several genetic markers from different populations have been studied, and the susceptibility of 
developing RF/RHD was first associated with some alleles of HLA (human leukocytes 
antigens) class II genes (DRB1, DQB and DQA), which are located on human chromosome 6. 
HLA alleles are involved in antigen recognition by T lymphocytes through the T cell receptor 
(TCR). Later, some studies showed that the TNF-┙ gene, located in the same region of this 
chromosome was also associated with the disease. The TNF-┙ gene encodes the inflammatory 
TNF alpha protein, which is involved in the inflammatory process mediating heart-tissue 
lesions in RHD. Several other associations have been established based on gene variability by 
studying single nucleotide polymorphisms (SNPs). These genes code for other proteins also 
involved with the immune response (innate and adaptive pathways) (see Diagram 1) 
(Guilherme et al., 2011). 
3.1.1 Molecular mimicry 
Molecular mimicry mediates cross-reactivity between streptococcal antigens and human 
proteins. Several autoantigens have been identified, including cardiac myosin epitopes, 
vimentin and other intracellular proteins. 
Several streptococcal and human cross-reactive antibodies have been found in the sera of RF 
patients and immunized rabbits and mice over the last 50 years and have been recently 
www.intechopen.com
 
S. pyogenes Infections and Its Sequelae 
 
127 
reviewed. Briefly, antibodies against N-acetyl ┚-D-glucosamine, a polysaccharide present in 
both the streptococcal cell wall and heart valvular tissue displayed cross reactivity against 
laminin, an extracellular matrix alpha-helical coiled-coil protein that surrounds heart cells 
and is also present in the valves (Cunningham, 2000; Guilherme et al., 2005).  
Among human proteins, cardiac myosin and vimentin seem to be the major target antigens. 
By using affinity-purified anti-myosin antibodies, Cunningham´s group identified a five 
amino acid residue (Gln-Lys-Ser-Lys-Gln) epitope of the N-terminal M5 and M6 proteins as 
cross-reactive with cardiac myosin (Cunningham et al., 1989). 
Cunningham´s group found that streptococcal and human cross-reactive antibodies 
upregulate the adhesion molecule VCAM-1 after binding to the endothelial surface, leading to 
inflammation, cellular infiltration and valve scarring (Gavin et al., 2000, Roberts et al, 2001). 
These data established the role of the heart–tissue cross-reactive antibodies (anti-cardiac 
myosin and laminin) in the early stages of inflammation and T cell infiltration in RHD lesions. 
Studies performed in the last 25 years showed that CD4+ cells are the major effectors of 
autoimmune reactions in the heart tissue in RHD patients (Raizada et al., 1984; Kemeny et 
al.,1989; Guilherme et al., 1995). However, the role of T cells in the pathogenesis of RF and 
RHD was demonstrated through the analysis of heart-tissue infiltrating T cell clones 
(Guilherme et al., 1995). Immunodominant peptides of the M5 protein (residues 81-96 and 
83-103) displayed cross-reactivity with valvular proteins and cardiac myosin peptides by 
molecular mimicry (Faé et al., 2006; Yoshinaga et al., 1995; Guilherme et al, 1995). These M5 
epitopes were also preferentially recognized by peripheral T lymphocytes from RHD 
patients when compared with normal individuals, mainly in the context of HLA-DR7 
(Guilherme et al., 2001). Analysis of the T cell receptors (TCR) of peripheral and intralesional 
T cells from RHD patients showed several antigen-driven oligoclonal T cell expansions at 
the site of heart-tissue lesions (Guilherme et al, 2000). These autoreactive cells are CD4+ and 
produce inflammatory cytokines (TNF and IFN┛). IL-4+ cells are found in the 
myocardium; however, these cells are very scarce in the valve lesions of RHD patients. IL-4 
is a Th2-type cytokine and plays a regulatory role in the inflammatory response mediated 
by Th1 cytokines. These findings indicate that the Th1/Th2 cytokine balance has a role in 
healing myocarditis, while the low numbers of IL-4-producing cells in the valves probably 
induced progressive and permanent valve damage (Guilherme et al, 2004).  
Three cases of RHD patients (clinical, surgical data) will be presented. Histological and 
immunological data obtained from peripheral blood and T-cell lines and T cell clones derived 
from heart-tissue infiltrating T cells of these patients are summarized in Tables 1 and 2. 
 
Patients 
Mitral Valve Myocardium (LA) 
Inflammation 
Rheumatic
Activity 
Neovasc Fibrosis Calcification Inflammation 
Rheumatic 
Activity 
Case 1 (++) 
AB-PR(+) 
VER(+) 
(+) (+) () AB-PR (+) (+) 
Case 2- (+) () () (++) () () () 
Case 3- 
1st surgery 
     (+) AB() 
2nd surgery (+)     (+) () 
LA-left atrium; AB-PR- Achoff Bodies in proliferative phase; Ver- verrucae, (-) negative;(+) mild;  
(++) moderate  
Table 1. Histological data of Rheumatic Heart Disease patients 
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Antigens 
recognized by T cell clones from myocardium and/or mitral valve
 
HLA 
Class II 
Heart-tissue 
Infiltrating 
Cells/field 
M5 protein
peptides 
Myocardium 
derived- proteins
Valve 
derived proteins 
CD4+ CD8+
Case  
# 1 
15,7, 52, 53 9.4     3.3 
M5 (81-96)
 
M5 (83-103)
M5 (163-177)
 
 
30-44 kDa; 
24-30 kDa 
LMM25(1607-1624)
>150 kDa, 90-150 kDa; 
65-90 kDa;43-65 kDa 
30-43 KDa 
90-150 kDa; 30-43 KDa 
Case  
# 2 
9, 11, 52,53 6.1     1.2 
M5(11-25)
M5 (81-96) 
M5 (83-103)
 
43-65 kDa 
90-150 kDa, 43-65 kDa 
90-150 kDa; 43-65 kDa 
Case  
# 3 
17, 13, 52, 4.5     0.9 
M5 (83-103) >150 kDa
 
LMM10(1413-1430)
LMM12(1439-1456)
90-150 kDa; 43-65 kDa; 
30-43 KDa 
Amino acid sequences of M5 protein were based on sequence published by Philips et al, 1981 and 
Manjula et al, 1985. M5 (81-96)-DKLKQQRDTLSTQKET; M5 (83-103)-LKQQRDTLSTQKETLEREVQN; 
M5-(163-177) ETIGTLKKILDETVK; cardiac myosin beta chain sequences published by Diederich et al, 
1989: LMM 10 (1413-1430) CSSLEKTKHRLQNEIEDL; LMM12 (1439-1456) AAAAALDKKRNFDKILA; 
LMM25 (1607-1624) RSRNEALRVKKKMEGDLN, (Guilherme et al, 1995, Faé et al, 2006). 
Table 2. T cells from heart-tissue of Rheumatic Heart Disease patients recognize 
streptococcal peptides and cardiac proteins.  
Case # 1 
Male 4 years old, presented mitral, aortic and tricuspid regurgitation, left ventricular 
diastolic diameter of 51 mm and systolic diameter of 34 mm, ejection fraction (LVEF) of 78%, 
left atrium (LA) of 40 mm, thickened pericardium.  
At surgery, mitral valve prolapse was observed with very long strings and small tears of 
rope. Mitral annulus was dilated. A mitral valve replacement was done. Heart biopsy 
showed chronic valvulitis with areas of mucoid collagen degeneration and papillary 
muscles with Aschoff nodules in the granulomatous stage (Table 1). 
Case # 2 
Male 6 years old, presented clinical features of fever, polyarthritis and carditis with mitral 
valve involvement. On this occasion, patient showed evidence of inflammatory activity; 
Gallium 67 positive scintigraphy; endomyocardial biopsy suggestive of rheumatic carditis. 
A left ventricular diastolic diameter of 59 mm, left ventricular systolic diameter of 39 mm, 
ejection fraction (LVEF) of 71% and left atrium (LA) of 52 mm were observed. Two valve 
correction surgeries were performed. Pathological examination of the mitral valve showed 
sequelae of chronic valvulitis with intense fibrosis and mucoid degeneration. 
Case #3 
Male 10 years old, presented clinical features of fever, polyarthritis and carditis with 
progressive cardiac heart failure and mitral and aortic shortcomings as well as relapses of 
acute outbreak by irregular use of secondary prophylaxis with benzathine penicillin and 
progression to chronic atrial fibrillation, culminating in death at 18 years of life. Increased 
www.intechopen.com
 
S. pyogenes Infections and Its Sequelae 
 
129 
left ventricular diastolic diameter (67/43 mm) and left atrial diameter of 62 mm, significant 
mitral regurgitation, aortic insufficiency and moderate impact tricuspid regurgitation with 
mild rebound were found. Subjected to two surgeries, first for mitral valve repair and 
prosthetic aortic and tricuspid valves, then for exchange of the mitral and aortic 
bioprostheses, and tricuspid valve repair. 
3.2 Post Streptococcal Glomerulonephritis (PSGN) 
Acute glomerulonephritis can occur sporadically or endemically as a result of infections of 
both the upper airways and skin by group A streptococcus strains.  
Genetic susceptibility factors are likely involved with the development of the disease. HLA 
class II alleles (DR4 and DRB1* 03011) have been found to be associated with PSGN 
compared to healthy controls. Genetic association with endothelial nitric oxide synthase 
intron 4 a/b (eNOSa/b) defined by variable numbers of tandem repeats (VNTR) 
polymorphism was also described (Ahn & Ingulli, 2008). 
The disease is mediated by immune complexes and complement pathway activation. 
Several theories seek to explain the formation of immune complexes in glomeruli. The most 
accepted one is that a streptococcal antigen, with affinity for the glomerular structures, can 
be deposited in the glomerulus, activating the host immune response and initiating 
development of immune complexes in situ (Rodriguez-Iturbe &  Bastford, 2007).  
Apparently, molecular mimicry between streptococcal antigens and glomerular proteins 
leads to tissue damage. Two antigens have been investigated as potential causes of PSGN: 
the plasmin receptor linked to nephritis (NAPlr), identified as glyceraldehyde 3-phosphate 
dehydrogenase, and a protein known as streptococcal pyrogenic exotoxin B (SpeB). Both are 
present in renal biopsies of patients with PSGN and are capable of activating the alternative 
pathway of the complement system. In addition, they are capable of promoting enhanced 
expression of adhesion molecules, facilitating inflammatory reactions mediated by cytokines 
(IL-6, TNF ┙, IL-8 and TGF ß). It seems that the nephritogenic properties of NAPlr and SpeB 
are related to the binding ability of plasmin, which facilitates the deposition of immune 
complexes (IgG and C3, properdin and C5) in the glomeruli and subsequent inflammation 
(Rodriguez-Iturbe & Bastford, 2007; Rodriguez-Iturbe & Musser, 2008). 
Molecular mimicry, as mentioned above, leads to the recognition of streptococcal antigens 
and laminin, collagen and glomerular basement membrane (GBM). Sub-epithelial 
localization of immune complexes and complement factors in the injured glomeruli points 
towards a crucial role of the host immune system in tissue destruction.  
As mentioned before, renal inflammation may result from a myriad of insults and is often 
characterized by the presence of infiltrating inflammatory leukocytes within the glomerulus 
or tubular interstitium. Accumulating evidence indicates that infiltrating leukocytes are the 
key to the induction of renal injury. 
Two cases of PSGN are presented in which anti-streptolysin O (ASO) was positive, 
indicating a previous infection by S. pyogenes.  
Case #1  
Male 6 years old, presented swollen eyes followed by bilateral periorbital edema followed by 
progression of lower limb edema and increased abdominal size, decreased urine volume and 
urine darkness. Lab tests detected hematuria, increased serum levels of urea (63.0 mg/dl) and 
creatinine (1.2 mg/dl). Decreased levels of complement (16.1 mg/dl) and fractions C3 and C4 
(both 11.7 mg/dl) were found. The patient also presented increased levels of ASO (1055 IU). 
www.intechopen.com
 
An Update on Glomerulopathies – Clinical and Treatment Aspects 
 
130 
Case # 2  
Male 15 years old, presented edema, hypertension, and gross hematuria and reported a skin 
abscess in the left leg 20 days before hospital admission. No previous signs of disease or 
significant co-morbidities were identified. Physical examination showed a 2+ lower edema, 
with no signs of current skin infections. Laboratory tests revealed 24 hr urine protein 2.4 
g/day, serum creatinine 2.9 mg/dl, hematuria, and positive ASO (> 200 IU). Renal 
ultrasound showed normal kidneys. After introducing antibiotic and controlling edema and 
hypertension with diuretics and anti-hypertensive drugs, the patient was subjected to a 
renal biopsy that showed a diffuse proliferative pattern, with focal endocapillary and 
mesangial proliferation with no cellular crescents.  
4. Frequencies of S. pyogenes strains collected at Clinical Hospital of the 
School of Medicine of the University of Sao Paulo 
Diverse S. pyogenes strains are related with the development of RF/RHD or PSGN and are 
considered as rheumatogenic and nephritogenic, respectively.  
We analyzed 177 samples obtained from diverse biological sources. Most samples were 
recovered from blood, throat and wound (Table 3).  
 
Source 
nº of 
cases
Strains identified 
emm1 emm87 emm22 emm12 emm77 emm6 emm75 emm89 st2904 others 
Throat 30 6 - 5 1 - 2 1 - 2 13 
Blood 58 10 6 3 7 5 3 2 1 - 21 
Wound 15 3 2 - - - - - 1 2 7 
Sputum 8 2 - 1 - 2 1 - - - 2 
Surgical 
wound 
5 - - 1 1 1 - - - - 2 
Ascitis 3 - - - - - - 1 - - 2 
Catheter 3 - - 1 - - - - - - 2 
Lymph  
node 
3 1 2 - - - - - - - - 
Ocular 
discharge 
3 2 - - - - - - - - 1 
Synovial 
fluid 
2 2 - - - - - - - - - 
Liquor 2 1 - - - - - - 1 - - 
Others 11 3 2 - - 1 - 1 1 - 3 
Table 3. Distribution of emm types according to biological source. 
The M1 type was more frequently observed. Figure 1 shows the frequencies of all strains 
analyzed.  Our results are similar to those previously published (Table 4). It is interesting to 
note that studies done by Schulman et al., 2004 and Ma et al., 2009 showed variability of 
frequencies for some streptococcus strains over different periods, probably due to seasonal 
influence. 
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Fig. 1. Prevalence of the M types in a sample from São Paulo 
Beta-hemolytic samples (177) obtained from diverse biological sites  at the Clinical Hospital, 
University of Sao Paulo during the period of 2001-2008. 
 
Country Year 
Nº 
isolates 
Nº of emm 
types 
identified 
Source 
More frequent emm 
types 
References 
Germany 2003-2007 586 49 invasive 
1, 28, 3, 12, 89, 4, 77, 6, 
75, 11, 118, 2, 83 
Imöhl et al., 
2010 
United 
States 
1995-1999 1586 17 invasive 
1, 28, 12, 3, 11, 4, 114, 
89, 17, 77, 33 
O´Brien et al., 
2002 
North 
America 
1nd-2000-2001 
2 nd-2001-2002 
1nd -975 
2nd- 1076 
1 nd -29 
2 nd - 31 
Non invasive 
1nd-12, 1, 28, 4, 3, 2 
2nd- 1, 12, 4, 28, 3, 2 
Schulman et 
al., 2004 
Barcelona 1999-2003 126 29 
invasive and 
non invasive 
1, 3, 4, 12,  28, 11, 77 
Rivera et al., 
2006 
Sweden 1986-2001 92 28 
invasive and 
non invasive 
1, 2, 4, 8, 12, 28, 66, 75 
Maripuu et al., 
2008 
Australia 2001-2002 107 22 
invasive and 
non invasive 
1, 4, 12, 28, 75 
Commons et 
al., 2008 
Hungary 2004-2005 26 8 invasive 
1, 80, 4, 28, 66, 81.1, 82, 
84 
Krucsó et al, 
2007 
China 
1nd-1993-1994 
2 nd-2005-2006 
1 nd -137 
2 nd -222 
1 nd -24 
2 nd - 9 
invasive and 
non invasive 
1 nd -3, 1, 4, 12, st1815, 6 
2 nd 12, 1 
Ma et al.,  2009 
Denmark 2003-2004 278 29 invasive 28, 1, 3, 89, 12 
Luca-Harari et 
al., 2008 
Norway 2006-2007 262 29 invasive 
28, 1, 82, 12, 4, 3, 87, 89, 
6 
Meisal et al., 
2010 
 
Two studies were reported for North America and China. 
Table 4. Distribution of emm types around the world 
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Diagram 1. Major events leading autoimmune reactions on both RHD and Glomerulonephritis 
5. Prospective vaccines against S. pyogenes 
Many studies have focused on developing a vaccine against S. pyogenes in order to prevent 
infection and its complications. There are four anti-group A streptococci (GAS) vaccine 
candidates based on the M protein and eight more candidates based on other streptococcal 
antigens, including group A CHO, C5a peptidase (SCPA), cysteine protease (Spe B), binding 
proteins similar to fibronectin, opacity factor, lipoproteins, Spes (super antigens) and 
streptococcal pili (Steer et al, 2009). 
We developed a vaccine epitope (StreptInCor) composed of 55 amino acid residues of the C-
terminal portion of the M protein that encompasses both T and B cell protective epitopes 
Peripheral Blood
 Streptococcal and human proteins: cross-reactions mediated by both antibodies and 
CD4+T cells  
 Inflammatory cytokines: IL-1, IL-6, IL-10, TNF- , IFN- ┛ 
 Circulating immune complexes  
S. pyogenes - Infections 
Genetic Susceptible Untreated Children and Teenagers 
Genetic markers Role 
 MBL, TLR2, FCN2, Fc┛ RIIA alleles  Innate immunity 
 HLA class II alleles  Adaptive immune response 
 Cytokines genes: TNF-┙, TGF ß1, IL-
1Ra, IL-10  
Mediators of inflammatory reactions  
(agonist or antagonist) 
Heart Tissue (RHD)
 Anti-laminin and/or cardiac myosin antibodies upregulate the VCAM-1 molecule 
in the endothelium surface leading to inflammation, cellular infiltration and valve 
scarring 
 Infiltrating T cells are predominantly CD4+ (~80%) 
 Antigen-driven oligoclonal T cells are expanded in the myocardium and valves 
 Intralesional T cell clones recognize streptococcal M peptides and heart-tissue 
proteins and cardiac myosin peptides (LMM) 
 High numbers of TNF- and IFN-┛ secreting mononuclear cells are mediators of 
myocardium and valvular inflammation 
 Low numbers of mononuclear cells IL-4+ in the valves probably lead to permanent 
and progressive valvular damage 
 
Kidney (Glomerulonephritis)  
 Streptococcal anti – SpeB  crossreactive antibodies recognize  NAPlr,  laminin,  
collagen and the glomerular basement membrane (GBM) antigens 
 Sub-epithelial deposition of immune complex and complement factors
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(Guilherme et al, 2006). The structural, chemical and biological properties of this peptide 
were evaluated, and we have shown that StreptInCor is a very stable molecule, an important 
property for a vaccine candidate (Guilherme et al, 2011). Furthermore, experiments with 
mice showed that this construct is immunogenic and safe (Guilherme et al, 2011). 
6. Conclusions 
The knowledge acquired in the last 25 years pointed out the molecular mimicry mechanism 
as one of the most important leading autoimmune reactions in RHD and PSGN. Although 
both diseases are triggered by S. pyogenes, RHD is mediated by both antibodies and T cells 
while PSGN is mainly due to immune complex deposition in the glomeruli. 
Several streptococcal cross reactive autoantigens were identified in both diseases. 
Many proteins and cardiac myosin epitopes were identified as putative cross-reactive 
autoantigens in RHD and collagen, glomerular basement membrane in PSGN. Laminin, 
another autoantigen is also involved in the cross reactivity in both diseases.  
Diagram 1 illustrates the major events leading to RHDand PSGN. 
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